Skip to content

A Comparative Evaluation of Safety and Patient Satisfaction between Single-Dose Alfentanil Injection and Propofol-Based Continuous Infusion in Outpatient Hysteroscopy Anesthesia

A Comparative Evaluation of Safety and Patient Satisfaction between Single-Dose Alfentanil Injection and Propofol-Based Continuous Infusion in Outpatient Hysteroscopy Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122367
Enrollment
Unknown
Registered
2026-04-13
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological diseases

Interventions

alfentanil infusion group:In the pump infusion group, anesthesia was induced 2 minutes prior to surgery with intravenous propofol (2 mg/kg) and alfentanil (5 µg/kg), administered slowly over 30–60 sec
Single-Dose Alfentanil Administration Group :In the single-dose alfentanil group, propofol (2 mg/kg) and alfentanil (10 µg/kg) were administered intravenously over 60 seconds, 2 minutes prior to surg

Sponsors

Maternal and Child Health Hospital of Hubei Province
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for hysteroscopy at this institution are anticipated to undergo procedures lasting no longer than 45 minutes. 2. Female patients aged 20–60 years. 3. American Society of Anesthesiologists (ASA) physical status classification I or II. 4. Absence of cardiovascular disease and normal hepatic and renal function, as confirmed by standard laboratory assessments. 5. Participation in this study is voluntary; eligible individuals who have received and comprehended the full informed consent information may indicate their willingness to participate by signing the written informed consent form.

Exclusion criteria

Exclusion criteria: 1. American Society of Anesthesiologists (ASA) physical status classification = III, or presence of severe cardiovascular disease or significantly compromised functional capacity; 2. Current or past psychiatric disorder requiring clinical management; 3. Current or recent use (within the preceding 30 days) of central nervous system–active medications, including antipsychotics, anxiolytics, antidepressants, or benzodiazepines; 4. Pre-procedural systolic blood pressure < 90 mmHg or diastolic blood pressure < 60 mmHg, and/or heart rate < 60 beats per minute measured in the clinical setting; 5. Known hypersensitivity to any study drug or its excipients; 6. History of poor recovery from anesthesia.

Design outcomes

Primary

MeasureTime frame
heart rate;Oxygen saturation;blood presure;Degree of satisfaction;intraoperative medication;awakening time;Postoperative adverse reactions;

Countries

China

Contacts

Public ContactYingyao Quan

Maternal and Child Health Hospital of Hubei Province

quanyingyao266@126.com+86 186 6507 3455

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026